ACUTA CAPITAL PARTNERS, LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
-11,888
(-8.3%)
New positions
11
Sold out positions
0
Turnover %
15.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VOGENX INC | 4,859 | NEW |
| SLN | 4,302 | NEW |
| IRD | 2,488 | NEW |
| RVMD | 1,691 | NEW |
| IRULYA THERAPEUTICS INC | 1,641 | NEW |
| ROIV | 1,519 | NEW |
| ORIC | 1,184 | NEW |
| LBRX | 1,084 | 115.4% |
| ARGX | 965 | 22.1% |
| FDMT | 903 | 13.4% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,015
(1.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|